Cardiopulmonary Exercise Testing and Oscillometry for the Evaluation of Dyspnea
Part of paid clinical trials in Rochester, New York.
- Sponsor
- University of Rochester
- Study ID
- NCT06554353
- Status
- Recruiting
Conditions
- Breathing, Mouth
- Dyspnea
- Lung Function Decreased
- Shortness of Breath
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Oscillometer — DEVICEThe tremoFlo C-100 Airwave Oscillometry System is intended to measure respiratory system impedance using the Forced Oscillation Technique (FOT).
Study Details
This study will determine if airway resistance to airflow and pressure, measured by Oscillometry, is associated with abnormal findings on Cardiopulmonary Exercise Testing in subjects who are experiencing shortness of breath.
Key Dates
- Start date
- Oct 29, 2024
- Status verified
- Oct 2025
- Primary completion
- May 1, 2026
- Completion
- Nov 30, 2026
Study Design
- Enrollment
- 50 participants (estimated)
Arms
- Arm: Subjects with dyspnea referred for Cardiopulmonary Exercise TestingSubjects with unexplained dyspnea referred for Cardiopulmonary Exercise Testing.
Primary Outcome Measure
Mean respiratory system resistance and reactance [ Time Frame: Single measurement, approximately day 1 ]
Central Contacts
- PATRICK DONOHUE, MD716-226-8429
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Highland Hospital | Rochester | New York | 14620 |
Find similar trials in Rochester, NY
By research site
Related Studies
- Body Composition Related Evaluation of Airway Tone and Hyper-rEactivity Using OscillometryRecruiting · University of Rochester · Rochester, New York
- Phase Resolved Functional Lung MRI and Oscillometry for the Observation of Healthy Lung FunctionNot Yet Recruiting · University of Rochester · Rochester, New York
- Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 InfectionRecruiting · Tufts Medical Center · Boston, Massachusetts
- Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PHPHASE2 · Recruiting · VA Office of Research and Development · Aurora, Colorado